Please check your internet connection and try again.
# Cystone Forte
## Overview
Cystone Forte is a polyherbal Ayurvedic formulation marketed by The Himalaya Drug Company. It is a concentrated version of the original Cystone formulation. Its primary pharmacological mechanism is hypothesized through lithotriptic (stone-dissolving) properties, antimicrobial action, and diuretic effects aimed at urinary tract health.
## Primary Indications
* Management and prevention of urolithiasis (kidney stones).
* Prophylaxis against stone recurrence post-lithotripsy or surgery.
* Adjuvant therapy in urinary tract infections (UTIs) and crystalluria.
## Adult Dosing
Standard dosing is **1 tablet twice daily**. Therapy duration varies based on the size and type of calculi; clinical guidelines suggest 3 to 6 months for stone management, monitored by imaging or metabolic workup. Consult local institutional protocols, as standardized clinical evidence for off-label use is limited.
## Pediatric Dosing
Safety and efficacy data in pediatric populations are not robust. **Use is generally discouraged without specialist pediatric nephrology oversight.** If prescribed, doses are typically halved (0.5 tablet twice daily) for older children/adolescents, but this is not based on validated pharmacokinetic trials.
## Dose Adjustments
There are no established guidelines for hepatic or renal dose adjustments due to the lack of pharmacokinetic data. Use with caution in patients with severe renal impairment where fluid balance or electrolyte levels must be tightly managed.
## Contraindications
* Known hypersensitivity to any of the ingredients (*Didymocarpus pedicellata, Saxifraga ligulata, Rubia cordifolia*, etc.).
* Large stones causing obstructive uropathy requiring immediate surgical intervention.
* Acute, symptomatic obstruction where herbal therapy may delay necessary surgical management.
## Adverse Effects
Generally well-tolerated. Reported side effects are rare but include:
* Gastrointestinal distress (nausea, mild abdominal cramping).
* Allergic skin reactions (rash, pruritus).
## Key Drug Interactions
* **Diuretics:** May have additive effects, increasing the risk of electrolyte imbalance.
* **Antibiotics:** May theoretically alter the pharmacokinetics of concurrent antibiotics; maintain a 2-hour interval.
* **Anticoagulants/Antiplatelets:** Some components (e.g., *Rubia cordifolia*) may possess mild anti-platelet properties; monitor for increased bleeding risk.
## Monitoring
* Baseline and periodic ultrasound or CT imaging to assess stone size and clearance.
* Urinalysis to monitor crystalluria and infection status.
* Serum creatinine and electrolyte levels (especially in patients with pre-existing renal dysfunction).
## Clinical Pearls
* **Not a Monotherapy:** Cystone Forte should not replace standard-of-care medical management (e.g., alpha-blockers for MET [Medical Expulsive Therapy] or surgical intervention) for acute colic or obstructive stones.
* **Hydration:** Efficacy is highly dependent on achieving adequate diuresis. Patients should maintain high fluid intake (2–3 liters daily).
* **Regulatory Status:** As an Ayurvedic formulation, it lacks the rigorous clinical trial standard required for conventional FDA-approved pharmaceuticals. Variations in active ingredient concentration may occur between batches.
***
**Educational Disclaimer:** This information is for educational purposes and does not constitute medical advice. Herbal formulations may vary by region and manufacturer. Always verify current prescribing information, ingredient lists, and clinical guidelines with your healthcare provider or a licensed pharmacist before initiating therapy.